Symbol: Name: ID: |
AADAC arylacetamide deacetylase (esterase) GFS:6090 |
Gene name: | AADAC |
Chromosome: | 3q21.3-q25.2 |
Previous Symbols: | |
Previous Names: | |
Aliases: | DAC, CES5A1 |
Name Aliases: | |
Locus Type: | gene with protein product |
Mouse Genome Database ID: | MGI:1915008 | Rat Genome Database ID: | RGD:631440 |
HGNC ID: | HGNC:17 | RefSeq IDs: | NM_001086 |
Entrez Gene ID: | Ensembl Gene ID: | ENSG00000114771 | |
VEGA IDs: | OTTHUMG00000159876 | UniProt ID: | P22760 |
UCSC ID: | uc003eze.2 | OMIM ID: | 600338 |
Pubmed: | PMID8063807 | ||
CCDS IDs: | CCDSCCDS33877.1 |
Arylacetamide deacetylase is an enzyme that in humans is encoded by the AADAC gene.
Microsomal arylacetamide deacetylase competes against the activity of cytosolic arylamine N-acetyltransferase, which catalyzes one of the initial biotransformation pathways for arylamine and heterocyclic amine carcinogens [provided by RefSeq, Jul 2008]. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Gene record to access additional publications.
Function: Arylacetamide deacetylation is an important enzyme activity in the metabolic activation of arylamine substrates to ultimate carcinogens. Displays major serine hydrolase activity in liver microsomes. Hydrolyzes also flutamide, which is an antiandrogen drug used for the treatment of prostate cancer that occasionaly causes severe hepatotoxicity. Displays cellular triglyceride lipase activity in liver. Increases intracellular fatty acids derived from hydrolysis of newly formed triglyceride stores.
Products for AADAC gene
Catalog | Product Name | Application | Company |
GFS:E06090 | arylacetamide deacetylase (esterase); ELISA kit | ELISA | n/a |
GFS:A06090 | arylacetamide deacetylase (esterase); Anti | ANTIBODIES | n/a |
GFS:P06090 | arylacetamide deacetylase (esterase); Protien | Protien | n/a |